C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 231/54 (2006.01) A61K 31/416 (2006.01)
Patent
CA 2613678
The present invention relates to novel cannabinoid receptor modulators, in particular cannabinoid 1 (CBl) or cannabinoid 2 (CB2) receptor modulators, and uses thereof for treating diseases, conditions and/or disorders modulated by a cannabinoid receptor (such as pain, neurodegenative disorders, eating disorders, weight loss or control, and obesity).
Cette invention concerne de nouveaux modulateurs des récepteurs des cannabinoïdes, en particulier des modulateurs du récepteur 1 (CB1) ou du récepteur 2 (CB2) des cannabinoïdes, et des utilisations de ces modulateurs pour traiter des maladies, des états et/ou des troubles modulés par un récepteur des cannabinoïdes (tels que la douleur, les troubles neurodégénératifs, les troubles de l'alimentation, la perte ou le contrôle du poids et l'obésité).
Balasubramanian Gopalan
Gullapalli Srinivas
Joshi Neelima Khairatkar
Muthuppalaniappan Meyyappan
Narayanan Shridhar
Auerbach Jonathan N.
Glenmark Pharmaceuticals S.a.
LandOfFree
Novel cannabinoid receptor ligands, pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel cannabinoid receptor ligands, pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel cannabinoid receptor ligands, pharmaceutical... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1437047